Sonam Dilwali, MD
Neurology · San Jose
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 4
- 1 carrier
- Office
- 1
Offices
1 location · Permanente Medical Group Inc · 10,928 clinicians in this group
Plans that list them
4 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Dilwali’s office at (408) 972-3000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Kaiser Permanente Dual Complete North P2 (HMO D-SNP) | Kaiser Permanente | Listed | Sep 1, 2026 |
| Kaiser Permanente Dual Complete North P23 (HMO D-SNP) | Kaiser Permanente | Listed | Sep 1, 2026 |
| Kaiser Permanente Sr Adv Basic Santa Clara (HMO) | Kaiser Permanente | Listed | Sep 1, 2026 |
| Kaiser Permanente Sr Adv Enhanced Santa Clara (HMO) | Kaiser Permanente | Listed | Sep 1, 2026 |
California Medical Board record
Licence A167292 · Current
Licensed to practise in California · since 2019 · expires 2027-12-31 · University of Texas Southwestern Medical Center, Southwestern Medical School.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Medicaid work
$4,474 in 2023
Medicaid paid $4,474 for 59 billed services this clinician did in 2023, up to 18 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Long return visit (40+ min) | 46 | $3,599 |
| Prolonged outpatient evaluation and management service(s) time with or without direct patient contact beyond the required time of the primary service when the primary service level has been selected using total time, each 15 minutes of total time (List separately in addition to the code of the outpatient Evaluation and Management service) | 13 | $875 |
| 2023 | 59 | 2 | 18 | $4,474 |
| 2022 | 49 | 2 | 17 | $3,265 |
See the largest Medicaid services in earlier years
2022
| Long return visit (40+ min) | 34 | $2,608 |
| Prolonged outpatient evaluation and management service(s) time with or without direct patient contact beyond the required time of the primary service when the primary service level has been selected using total time, each 15 minutes of total time (List separately in addition to the code of the outpatient Evaluation and Management service) | 15 | $658 |
Drugs they prescribed that Part D paid
$60,147
Pharmacies billed $60,147 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 352) in 2024. At or below the middle of the specialty; the typical neurology clinician is at 0%.
336 generic and 16 brand-name prescriptions · $60,147 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Dalfampridine Er | 21 | $4,236 | $202 |
| Carbidopa-Levodopa | 66 | $2,874 | $44 |
| Gabapentin | 39 | $886 | $23 |
| Lacosamide | 15 | $628 | $42 |
| Levetiracetam | 17 | $482 | $28 |
See all 9 drugs
| Dalfampridine Er | 21 | $4,236 | $202 |
| Carbidopa-Levodopa | 66 | $2,874 | $44 |
| Gabapentin | 39 | $886 | $23 |
| Lacosamide | 15 | $628 | $42 |
| Levetiracetam | 17 | $482 | $28 |
| Propranolol | 12 | $378 | $31 |
| Lamotrigine | 19 | $328 | $17 |
| Pregabalin | 17 | $326 | $19 |
| Pantoprazole | 17 | $124 | $7 |
Year by year
| 2024 | 352 | 127 | 0% (0) | 5% | $60,147 |
| 2023 | 236 | 78 | None | None | $130,441 |
| 2022 | 91 | 30 | 0% (0) | 14% | $22,510 |
| 2019 | 24 | None | None | None | $532 |
| 2018 | 13 | None | None | None | $1,139 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 8 drugs
| Dalfampridine Er | 28 | $13,483 | $482 |
| Mycophenolate Mofetil | 13 | $787 | $61 |
| Carbidopa-Levodopa | 16 | $590 | $37 |
| Levetiracetam | 12 | $582 | $49 |
| Gabapentin | 12 | $423 | $35 |
| Baclofen | 13 | $251 | $19 |
| Prednisone | 12 | $180 | $15 |
| Pantoprazole | 15 | $116 | $8 |
Money from drug and device companies
$48 in 2025
| 2025 | 1 | 2 | None | $48 |
| 2024 | 1 | 1 | None | $119 |
| 2023 | 4 | 6 | None | $429 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| LivaNova USA | Vns Therapy Sentiva Model 1000 Generator | $48 | 2 payments
|
See all 2 published payments
| LivaNova USA | Meals · 2025-09-15 | Vns Therapy Sentiva Model 1000 Generator | $33 |
| LivaNova USA | Meals · 2025-08-28 | Vns Therapy Sentiva Model 1000 Generator | $15 |
See earlier years (2024, 2023)
2024: $119
| Novartis Pharmaceuticals | Kesimpta | $119 | 1 payment
|
2023: $429
| AbbVie | Qulipta | $146 | 2 payments
|
| E.R. Squibb & Sons L.L.C. | None | $125 | 1 payment
|
| Novartis Pharmaceuticals | Kesimpta | $114 | 2 payments
|
| Celgene | Zeposia | $45 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 75.0 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1720578875
- Licence
- CA A167292California A167292: Current · expires 2027-12-31
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Neurology (2084N0400X); Student in a training program (390200000X)
- Mailing address
- Po Box 743749, Los Angeles, CA, 90074
- NPI first listed
- 2018-05-15
- NPI last updated
- 2023-08-01
- NPI record certified
- 2023-08-01
This is when the NPI record was last certified, not a medical board exam.
This office lists an electronic records connection.